- All sections
- C - Chemistrymetallurgy
- C07K - Peptides
- C07K 5/02 - Peptides having up to four amino acids in a fully defined sequenceDerivatives thereof containing at least one abnormal peptide link
Patent holdings for IPC class C07K 5/02
Total number of patents in this class: 753
10-year publication summary
|
57
|
50
|
70
|
55
|
58
|
39
|
27
|
41
|
45
|
29
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| SeaGen Inc | 594 |
21 |
| Janssen Pharmaceutica N.V. | 3367 |
15 |
| ImmunoGen, Inc. | 399 |
13 |
| F. Hoffmann-La Roche AG | 7948 |
12 |
| Hoffmann-La Roche Inc. | 3478 |
12 |
| Endocyte, Inc. | 109 |
12 |
| Kyowa Hakko Bio Co., Ltd. | 290 |
11 |
| Revolution Medicines, Inc. | 250 |
10 |
| Novartis AG | 10721 |
9 |
| The Regents of the University of California | 20108 |
8 |
| Siemens Medical Solutions USA, Inc. | 1516 |
8 |
| President and Fellows of Harvard College | 6002 |
8 |
| Dana-Farber Cancer Institute, Inc. | 2596 |
8 |
| Pfizer Inc. | 3386 |
7 |
| Ajinomoto Co., Inc. | 2301 |
7 |
| Cornell University | 3339 |
7 |
| Zymeworks Inc. | 262 |
7 |
| Merck Patent GmbH | 5767 |
6 |
| Ambrx, Inc. | 183 |
6 |
| Karus Therapeutics Limited | 27 |
6 |
| Other owners | 560 |